***Background.*** Carbapenem-resistant Enterobacteriaceae (CRE) and carbapenem-resistant *Acinetobacter* (CRAB) are increasingly reported in the United States and cause infections with high mortality. We initiated a laboratory and population-based surveillance program to describe the epidemiology of CRE and CRAB.

***Methods.*** We defined CRE as *Escherichia coli*, *Enterobacter* spp, or *Klebsiella* spp nonsusceptible to ≥1 carbapenem (excluding ertapenem) and resistant to all 3rd generation cephalosporins tested, and CRAB as *A. baumannii* nonsusceptible to ≥1 carbapenem (excluding ertapenem). CRE and CRAB isolates from sterile sites or urine collected in residents of 3 metropolitan areas in GA, MN, and OR in 2012 were included. Rates were based on 2012 census data. We reviewed patient charts and classified isolates as hospital-onset (HO) (collected \>3 days after admission); healthcare-associated, community-onset (HACO) (collected ≤3 days after admission with hospitalization, dialysis, long-term care residence, or surgery in the prior year or with an indwelling device at time of culture); or community-associated (CA) (collected ≤3 days after admission and lacking the above healthcare exposures). Polymerase chain reaction was used to test available CRE for selected carbapenemases.

***Results.*** Of 327 isolates, 213 were CRE (169 patients), 114 were CRAB (100 patients). Most CRE (88%) and CRAB (73%) were from urine; 9% and 25% were from blood respectively. CRE and CRAB incidence (per 100,000 population) was significantly lower in OR (CRE: 0.35, CRAB: 0) and MN (CRE: 1.88, CRAB: 0.12), compared to GA (CRE: 4.58, CRAB: 2.93). Most CRE (72%) and CRAB (62%) isolates were classified as HACO; of these, 49% of CRE and 66% of CRAB were from patients recently in long-term care settings. *K. pneumoniae* carbapenemase was detected in 51% of CRE (*K. pneumoniae* \[19/23; 83%\], *E. coli* \[1/8; 13%\], *E. cloacae* \[6/9; 67%\], *E. aerogenes* \[1/13; 8%\]); no other carbapenemases were detected.

***Conclusion.*** Most CRE and all CRAB were detected in patients with healthcare exposures. CRE and CRAB incidence varied substantially across surveillance sites. Many CRE meeting our definition do not harbor carbapenemases; whether these organisms pose the same threat as carbapenemase-producing CRE is not known.
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